Riskpilot← Back to searchSign inGet full accessSN Hälsa AB
ABActiveOrg 5590642749Bältargatan 5General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2025
SEK 5,5M
+5% vs 2024
EBITDA margin
43.2%
-10% vs 2024
Equity ratio
63.6%
Financial strength
Net profit 2025
SEK 1,7M
-20% vs 2024
| Revenue | SEK 5,5M | +5% |
| EBITDA | SEK 2,4M | -10% |
| Net profit | SEK 1,7M | -20% |
| Total assets | SEK 8,9M | +68% |
| Equity | SEK 5,7M | +24% |
| Employees | 1 | — |
Legal name
SN Hälsa AB
Org number
5590642749
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 maj 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Läkartjänster samt driva HVB hem, förvalta fastigheter
Address
Bältargatan 5
Email
shah-darvesh@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 794 | 3 772 | 3 995 | 5 195 | 5 475 |
| Staff expenses | — | — | — | −1 550 | −1 709 |
| EBITDA | 1 340 | 1 708 | 1 746 | 2 627 | 2 366 |
| Depreciation & amort. | −0 | −27 | −48 | −74 | −208 |
| EBIT | 1 340 | 1 681 | 1 698 | 2 553 | 2 158 |
| Net financials | −1 | — | −2 | −1 | −6 |
| Profit before tax | 1 339 | 1 681 | 1 697 | 2 617 | 2 152 |
| Tax | −288 | −349 | −352 | −540 | −490 |
| Net profit | 1 051 | 1 332 | 1 345 | 2 077 | 1 662 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 508 | 2 993 | 3 650 | 5 325 | 8 923 |
| Equity | 1 368 | 2 264 | 2 939 | 4 586 | 5 678 |
| Long-term debt | 0 | 0 | 0 | — | 2 500 |
| Short-term debt | 1 076 | 664 | 646 | 739 | 745 |
| Total debt | 1 076 | 664 | 646 | 739 | 3 245 |
EBITDA margin
43.2%
This company
15.8%
Market median
+173% vs market
20212025
Equity ratio
63.6%
This company
38.2%
Market median
+66% vs market
20212025
Return on equity
29.3%
This company
18.4%
Market median
+59% vs market
20212025
Net profit margin
30.4%
This company
8.1%
Market median
+275% vs market
20212025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EK Audit | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SN Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Kristina Hed | Audit | 0 companies |
| Selma Nazri | Deputy Board Member | 0 companies |
| Shah Nazri | Board of Directors | 0 companies |